194 related articles for article (PubMed ID: 37294480)
1. The crosstalk between ubiquitin-conjugating enzyme E2Q1 and p53 in colorectal cancer: An in vitro analysis.
Rasouli M; Khakshournia S; Vakili O; Dastghaib S; Seghatoleslam A; Shafiee SM
Med Oncol; 2023 Jun; 40(7):199. PubMed ID: 37294480
[TBL] [Abstract][Full Text] [Related]
2. UBE2Q1 in a Human Breast Carcinoma Cell Line: Overexpression and Interaction with p53.
Shafiee SM; Rasti M; Seghatoleslam A; Azimi T; Owji AA
Asian Pac J Cancer Prev; 2015; 16(9):3723-7. PubMed ID: 25987028
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Interaction of UBE2Q1 with B4GALT1 and P53: Experimental and Molecular Modeling Study.
Ghasemi H; Seghatoleslam A; Fahmideh Kar MA; Mahbudi L; Fard BG; Jamshidi M
Protein Pept Lett; 2023; 30(8):668-678. PubMed ID: 37198983
[TBL] [Abstract][Full Text] [Related]
4. Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo.
Saville MK; Sparks A; Xirodimas DP; Wardrop J; Stevenson LF; Bourdon JC; Woods YL; Lane DP
J Biol Chem; 2004 Oct; 279(40):42169-81. PubMed ID: 15280377
[TBL] [Abstract][Full Text] [Related]
5. UBE2Q1 expression in human colorectal tumors and cell lines.
Shafiee SM; Seghatoleslam A; Nikseresht M; Hosseini SV; Alizadeh-Naeeni M; Safaei A; Owji AA
Mol Biol Rep; 2013 Dec; 40(12):7045-51. PubMed ID: 24197692
[TBL] [Abstract][Full Text] [Related]
6. Bilirubin, an endogenous antioxidant that affects p53 protein and its downstream apoptosis/autophagy-related genes in LS180 and SW480 cell culture models of colorectal cancer.
Niknam M; Maleki MH; Khakshournia S; Rasouli M; Vakili O; Shafiee SM
Biochem Biophys Res Commun; 2023 Sep; 672():161-167. PubMed ID: 37354609
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of UBE2Q1 is associated with neuronal apoptosis in rat brain cortex following traumatic brain injury.
Wan C; Chen J; Hu B; Zou H; Li A; Guo A; Jiang J
J Neurosci Res; 2014 Jan; 92(1):1-12. PubMed ID: 24166684
[TBL] [Abstract][Full Text] [Related]
8. p53 Ubiquitination and proteasomal degradation.
Love IM; Shi D; Grossman SR
Methods Mol Biol; 2013; 962():63-73. PubMed ID: 23150437
[TBL] [Abstract][Full Text] [Related]
9. Dynamics in the p53-Mdm2 ubiquitination pathway.
Brooks CL; Gu W
Cell Cycle; 2004 Jul; 3(7):895-9. PubMed ID: 15254415
[TBL] [Abstract][Full Text] [Related]
10. The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.
Sparks A; Dayal S; Das J; Robertson P; Menendez S; Saville MK
Oncogene; 2014 Sep; 33(38):4685-96. PubMed ID: 24121268
[TBL] [Abstract][Full Text] [Related]
11. Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation.
Hjerpe R; Aillet F; Lopitz-Otsoa F; Lang V; Torres-Ramos M; Farrás R; Hay RT; Rodríguez MS
Int J Biochem Cell Biol; 2010 May; 42(5):725-35. PubMed ID: 20080206
[TBL] [Abstract][Full Text] [Related]
12. Upregulated expression of ubiquitin-conjugating enzyme E2Q1 (UBE2Q1) is associated with enhanced cell proliferation and poor prognosis in human hapatocellular carcinoma.
Chang R; Wei L; Lu Y; Cui X; Lu C; Liu L; Jiang D; Xiong Y; Wang G; Wan C; Qian H
J Mol Histol; 2015 Feb; 46(1):45-56. PubMed ID: 25311764
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
[TBL] [Abstract][Full Text] [Related]
14. Auto-ubiquitination of Mdm2 enhances its substrate ubiquitin ligase activity.
Ranaweera RS; Yang X
J Biol Chem; 2013 Jun; 288(26):18939-46. PubMed ID: 23671280
[TBL] [Abstract][Full Text] [Related]
15. Induction of cell proliferation, clonogenicity and cell accumulation in S phase as a consequence of human UBE2Q1 overexpression.
Fahmidehkar MA; Shafiee SM; Eftekhar E; Mahbudi L; Seghatoleslam A
Oncol Lett; 2016 Sep; 12(3):2169-2174. PubMed ID: 27602158
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of tumor suppressor p53 on proinflammatory chemokine expression in ovarian cancer cells by reducing proteasomal degradation of IκB.
Son DS; Kabir SM; Dong YL; Lee E; Adunyah SE
PLoS One; 2012; 7(12):e51116. PubMed ID: 23300534
[TBL] [Abstract][Full Text] [Related]
17. Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53.
Dayal S; Sparks A; Jacob J; Allende-Vega N; Lane DP; Saville MK
J Biol Chem; 2009 Feb; 284(8):5030-41. PubMed ID: 19098288
[TBL] [Abstract][Full Text] [Related]
18. Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice.
Jung CR; Lim JH; Choi Y; Kim DG; Kang KJ; Noh SM; Im DS
J Clin Invest; 2010 Dec; 120(12):4493-506. PubMed ID: 21060154
[TBL] [Abstract][Full Text] [Related]
19. Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity.
Nomura K; Klejnot M; Kowalczyk D; Hock AK; Sibbet GJ; Vousden KH; Huang DT
Nat Struct Mol Biol; 2017 Jul; 24(7):578-587. PubMed ID: 28553961
[TBL] [Abstract][Full Text] [Related]
20. Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination.
Frum RA; Love IM; Damle PK; Mukhopadhyay ND; Palit Deb S; Deb S; Grossman SR
Mol Cancer Res; 2016 May; 14(5):423-36. PubMed ID: 26965143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
